TipRanks
Bonus Biogroup Ltd. (BBIXF)
OTHER OTC:BBIXF
US Market
BBIXF
Bonus Biogroup
RESEARCH TOOLSreports

Bonus Biogroup (BBIXF) Income Statement

12 Followers

Bonus Biogroup Income Statement

Last quarter (Q2 2026), Bonus Biogroup's total revenue was ₪0.00, a decrease of ― from the same quarter last year. In Q2, Bonus Biogroup's net income was ₪-6.02M. See Bonus Biogroup’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 0.00₪ 0.00₪ 0.00₪ 0.00₪ 0.00
Gross Profit
₪ -2.76M₪ -2.79M₪ -2.76M₪ -3.37M₪ -4.10M
Operating Expenses
₪ 19.88M₪ 27.84M₪ 25.58M₪ 37.05M₪ 36.66M
Depreciation and Amortization
₪ 2.76M₪ 2.79M₪ 1.65M₪ 2.66M₪ 1.48M
EBITDA
₪ -19.88M₪ -24.25M₪ -28.14M₪ -35.13M₪ -88.01M
Operating Income
₪ -22.64M₪ -27.84M₪ -28.34M₪ -37.05M₪ -64.73M
Other Income/Expenses
₪ -1.85M₪ 10.00K₪ -184.00K₪ -1.66M₪ -25.34M
Pretax Income
₪ -24.49M₪ -27.83M₪ -28.53M₪ -38.70M₪ -90.08M
Net Income
₪ -24.49M₪ -27.83M₪ -28.53M₪ -38.70M₪ -90.08M
Per Share Metrics
Basic EPS
₪ -0.04₪ -0.02₪ -0.02₪ -0.06₪ -0.16
Diluted EPS
₪ -0.04₪ -0.02₪ -0.02₪ -0.06₪ -0.16
Weighted Average Shares Outstanding
 669.70M 1.17B 1.17B 621.08M 579.12M
Weighted Average Shares Outstanding (Diluted)
 669.70M 1.17B 1.17B 621.08M 579.12M
Currency in ILS

Bonus Biogroup Earnings and Revenue History